Restrictive approach to blood cell transfusions safe for heart surgery patients

In a recent clinical trial of higher risk patients undergoing cardiopulmonary bypass surgery, a restrictive approach to blood cell transfusions resulted in fewer transfusions without putting patients at increased risk of acute kidney injury. The findings appear in an upcoming issue of JASN.

Reducing blood cell transfusions during surgery could prevent transfusion-related adverse effects, conserve the , and reduce healthcare costs, but it might also have negative effects on the kidneys due to a variety of mechanisms. To investigate, Amit X. Garg, MD, Ph.D., (Lawson Health Research Institute in Ontario) and his colleagues conducted a randomized clinical trial called TRICS-III. The trial included 4531 higher risk undergoing cardiopulmonary bypass surgery across 73 centers in 19 countries. Patients were randomized to a restrictive transfusion approach (transfuse only if hemoglobin is below 7.5 g/dL) or a more liberal approach (transfuse if hemoglobin is less than 9.5 g/dL).

Patients in the restrictive group received 38% fewer transfusions than patients in the liberal group (1.8 vs. 2.9 transfusions, on average, respectively), and the approaches were equally safe with respect to risk of acute kidney injury. Risk were similar between patients with and without before surgery.

"With over 20 million cardiac surgeries performed worldwide each year—with it being one of the more common reasons for using blood in the hospital and an average of about 3 units of red blood cells used per patient—this suggests that approximately 20 million units of blood transfusions could be avoided each year without influencing the chance that a patient will develop post-operative kidney injury," said Dr. Garg.

In an accompanying editorial, Iain Macdougall, MD, Ph.D. (King's College Hospital, in the UK) and Toby Richards, MD (University of Western Australia) noted that the study represents one of the largest trials assessing acute kidney injury ever performed, but they pointed to several limitations.

More information: "Safety of a Restrictive versus Liberal Approach to Red Blood Cell Transfusion on the Outcome of AKI in Patients Undergoing Cardiac Surgery: A Randomized Clinical Trial," DOI: 10.1681/ASN.2019010004

Citation: Restrictive approach to blood cell transfusions safe for heart surgery patients (2019, June 20) retrieved 25 March 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Steroid use during cardiac bypass surgery did not reduce risk of severe kidney injury


Feedback to editors